C. Knackstedt

Venner, M. F. G. H. M., Gevers, T. J. G., Ploum, F., Habets, J., Raafs, A. G., Weerts, J., Heymans, S. R. B., van der Leij, C., de Haan, M. W., Verdonschot, J. A. J., Kramer, M., & Knackstedt, C. (2025). Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 431, Article 133226. https://doi.org/10.1016/j.ijcard.2025.133226

Weerts, J., Mourmans, S. G. J., Lopez-Martinez, H., Domingo, M., Aizpurua, A. B., Henkens, M. T. H. M., Achten, A., Lupon, J., Brunner-La Rocca, H.-P., Knackstedt, C., Bayes-Genis, A., & van Empel, V. P. M. (2025). Inter-atrial block as a predictor of adverse outcomes in patients with HFpEF. Esc heart failure, 12(3), 2287-2297. https://doi.org/10.1002/ehf2.15179

Achten, A., van Empel, V. P. M., Weerts, J., Mourmans, S., Brunner-La Rocca, H.-P., Sanders-van Wijk, S., & Knackstedt, C. (2025). Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction. Netherlands Heart Journal, 33(6), 193-198. https://doi.org/10.1007/s12471-025-01954-3

Wiethoff, I., Schoonvelde, S. A. C., de Boer, R. A., Evers, S. M. A. A., Germans, T., Hirsch, A., Knackstedt, C., Te Rijdt, W. P., van Slegtenhorst, M. A., Schinkel, A. F. L., Zwetsloot, P.-P., Michels, M., & Hiligsmann, M. (2025). Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study. Open Heart, 12(1), Article e003143. https://doi.org/10.1136/openhrt-2024-003143

Weerts, J., Aizpurua, A. B., Patel, R. B., van de Bovenkamp, A. A., Amin, H., Sanders-van Wijk, S., Mourmans, S. G. J., Achten, A., Handoko, M. L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Shah, S. J., Knackstedt, C., & van Empel, V. P. M. (2025). A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. European journal of heart failure. Advance online publication. https://doi.org/10.1002/ejhf.3651

Tingen, H. S. A., Berends, M., Tubben, A., van der Meer, P., Slart, R. H. J. A., Bijzet, J., van der Zwaag, P. A., Kimmich, C., Knackstedt, C., Muntinghe, F. L. H., Houwerzijl, E. J., Hazenberg, B. P. C., & Nienhuis, H. L. A. (2025). Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging. Advance online publication. https://doi.org/10.1007/s00259-025-07328-6

Mourmans, S. G. J., Achten, A., Hermans, R., Scheepers, M. J. E., D'Alessandro, E., Swennen, G., Woudstra, J., Appelman, Y., Goor, H. V., Schalkwijk, C., Knackstedt, C., Weerts, J., Eringa, E. C., & van Empel, V. P. M. (2025). The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction. Cardiovascular Diabetology, 24(1), Article 182. https://doi.org/10.1186/s12933-025-02679-8

Vranken, N. P. A., Li, X., Bouman, H., Mourmans, S. G. J., Achten, A., Aizpurua, A. B., Brunner-La Rocca, H.-P., Knackstedt, C., van Empel, V. P. M., & Weerts, J. (2025). Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction. Cardiovascular Diabetology, 24(1), Article 156. https://doi.org/10.1186/s12933-025-02708-6

Achten, A., Weerts, J., van Koll, J., Ghossein, M., Mourmans, S. G. J., Aizpurua, A. B., van Stipdonk, A. M. W., Vernooy, K., Prinzen, F. W., Rocca, H.-P. B.-L., Knackstedt, C., & van Empel, V. P. M. (2025). Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction. IJC Heart and Vasculature, 57, Article 101622. https://doi.org/10.1016/j.ijcha.2025.101622

Gingele, A. J., Amin, H., De Wit, K., Jacobsen, M., Hageman, A., van der Mierden, K., Brandts, J., Weerts, J., Barrett, M., Dixon, L. J., Hill, L., Knackstedt, C., & Brunner-La Rocca, H.-P. (2025). Developing an artificial intelligence-based decision engine for disease-modifying therapy in heart failure: a pilot study. European Heart Journal - Digital Health, 6(2), 285-288. https://doi.org/10.1093/ehjdh/ztad075